figshare
Browse
temi_a_1601030_sm6170.pdf (259.54 kB)

Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice

Download (259.54 kB)
Version 3 2019-12-19, 00:18
Version 2 2019-04-12, 09:45
Version 1 2019-04-05, 05:42
journal contribution
posted on 2019-12-19, 00:18 authored by Florine E. M. Scholte, Jessica R. Spengler, Stephen R. Welch, Jessica R. Harmon, JoAnn D. Coleman-McCray, Brendan T. Freitas, Markus H. Kainulainen, Scott D. Pegan, Stuart T. Nichol, Éric Bergeron, Christina F. Spiropoulou
Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice

Funding

This study was supported by a [Grant Number R01AI109008] from NIAID (National Institute of Allergy and Infectious Diseases) and by CDC Emerging Infectious Disease Research Core Funds.

History

Usage metrics

    Emerging Microbes and Infections

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC